Bioportfolio: Lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue
- 9 May 2006
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 103 (19) , 7450-7453
- https://doi.org/10.1073/pnas.0602259103
Abstract
Human erythrovirus is a minute, single-stranded DNA virus causing many diseases, including erythema infectiosum, arthropathy, and fetal death. After primary infection, the viral genomes persist in solid tissues. Besides the prototype, virus type 1, two major variants (virus types 2 and 3) have been identified recently, the clinical significance and epidemiology of which are mostly unknown. We examined 523 samples of skin, synovium, tonsil, or liver (birth year range, 1913-2000), and 1,640 sera, by qualitative and quantitative molecular assays for the DNA of human erythroviruses. Virus types 1 and 2 were found in 132 (25%) and 58 (11%) tissues, respectively. DNA of virus type 1 was found in all age groups, whereas that of type 2 was strictly confined to those subjects born before 1973 (P < 0.001). Correspondingly, the sera from the past two decades contained DNA of type 1 but not type 2 or 3. Our data suggest strongly that the newly identified human erythrovirus type 2 as well as the prototype 1 circulated in Northern and Central Europe in equal frequency, more than half a century ago, whereafter type 2 disappeared from circulation. Type 3 never attained wide occurrence in this area during the past > or =70 years. The erythrovirus DNA persistence in human tissues is lifelong and represents a source of information about our past, the Bioportfolio, which, at the individual level, provides a registry of one's infectious encounters, and at the population level, a database for epidemiological and phylogenetic analyses.Keywords
This publication has 58 references indexed in Scilit:
- Reactivity of Genotype-Specific Recombinant Proteins of Human Erythrovirus B19 with Plasmas from Areas Where Genotype 1 or 3 Is EndemicJournal of Clinical Microbiology, 2006
- Parvovirus B19-Induced Apoptosis of HepatocytesJournal of Virology, 2004
- Latent Epstein–Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA- and DNA-in situ hybridizationLaboratory Investigation, 2004
- Contamination of coagulation factor concentrates with human parvovirus B19 genotype 1 and 2Thrombosis and Haemostasis, 2004
- Prevalence of Parvovirus B19 in Liver Tissue: No Association with Fulminant Hepatitis or Hepatitis‐Associated Aplastic AnemiaThe Journal of Infectious Diseases, 2003
- High Mutant Frequency in Populations of a DNA Virus Allows Evasion from Antibody Therapy in an Immunodeficient HostJournal of Virology, 2003
- Etiology of Measles‐ and Rubella‐like Illnesses in Measles, Mumps, and Rubella–Vaccinated ChildrenThe Journal of Infectious Diseases, 1998
- Parvovirus B19 Clearance from Peripheral Blood after Acute InfectionThe Journal of Infectious Diseases, 1995
- Risk of Human Parvovirus B19 Infections among School and Hospital Employees during Endemic PeriodsThe Journal of Infectious Diseases, 1993
- Human parvovirus (B19) and erythema infectiosumThe Journal of Pediatrics, 1985